The Codon-Modified Virotherapeutic Codalytic™ Modulates The Tumor Microenvironment In Models With Different Immune Contextures

Time: 4:45 pm
day: Day One


  • Overview of Codagenix’s codon-modification platform and the design of CodaLytic
  • Changes in the tumor microenvironment induced by CodaLytic, alone or in combination with checkpoint inhibitors, in murine models and a human tumor explant system
  • Connection to efficacy outcomes, incl. tumor growth, survival and cytotoxicity